Patents by Inventor Todd Maddux

Todd Maddux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Endoparasitic depsipeptides
    Patent number: 11771738
    Abstract: The present invention provides cyclic depsipeptides of Formula (1), stereoisomers thereof, and veterinary acceptable salts thereof wherein each of R1, R2, R3, R4, L1, and L2 are as defined herein. The present invention also contemplates compositions, methods of treatment, and uses as a medicament to treat an animal for an endoparasitic infection with a Formula (1) compound.
    Type: Grant
    Filed: May 7, 2019
    Date of Patent: October 3, 2023
    Assignee: Zoetis Services LLC
    Inventors: Todd Maddux, Matthew W. Bedore, Paul D. Johnson, Tomasz Respondek, Susan M. K. Sheehan, Graham M. Kyne, Richard A. Ewin, Rajendran Vairagoundar, Michael P. Curtis
  • Endoparasitic Depsipeptides
    Publication number: 20220323540
    Abstract: The present invention provides cyclic depsipeptides of Formula (1), stereoisomers thereof, and veterinary acceptable salts thereof wherein each of R1, R2, R3, R4, L1, and L2 are as defined herein. The present invention also contemplates compositions, methods of treatment, and uses as a medicament to treat an animal for an endoparasitic infection with a Formula (1) compound.
    Type: Application
    Filed: May 7, 2019
    Publication date: October 13, 2022
    Inventors: Todd Maddux, Matthew W. Bedore, Paul D. Johnson, Tomasz Respondek, Susan M.K. Sheehan, Graham M. Kyne, Richard A. Ewin, Rajendran Vairagoundar, Michael P. Curtis
  • SUBSTITUTED ISOXAZOLINE DERIVATIVES
    Publication number: 20110251247
    Abstract: This invention recites substituted isoxazoline derivatives of Formula (1) or a veterinarily acceptable salt thereof, with parasiticidal activity, compositions thereof, and their use as a parasiticide in animals or birds where R1a, R1b, R1c, R2, R3, and n are as described herein.
    Type: Application
    Filed: April 6, 2011
    Publication date: October 13, 2011
    Applicant: PFIZER INC.
    Inventors: Nathan Anthony Logan Chubb, Todd Maddux, Sanjay Menon
  • Pyridine [3,4-b] pyrazinones
    Patent number: 7902195
    Abstract: Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I: wherein R2, R6A, R6B and R8 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, synthetic methods, and intermediates are also disclosed.
    Type: Grant
    Filed: April 20, 2007
    Date of Patent: March 8, 2011
    Assignee: Pharmacia & Upjohn Company LLC
    Inventors: Robert O Hughes, Andrew Simon Bell, David Graham Brown, Dafydd Owen, Michael John Palmer, Christopher Phillips, David L. Brown, Yvette M. Fobian, John N. Freskos, Steven E. Heasley, E. Jon Jacobsen, Todd Maddux, Brent Mischke, John M. Molyneaux, Joseph B. Moon, D. Joseph Rogier, Jr., Michael B. Tollefson, John K. Walker
  • Pyridine [3,4-b] Pyrazinones
    Publication number: 20070249615
    Abstract: Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I: wherein R2, R6A, R6B and R8 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, synthetic methods, and intermediates are also disclosed.
    Type: Application
    Filed: April 20, 2007
    Publication date: October 25, 2007
    Inventors: Robert Hughes, Andrew Bell, David Brown, Dafydd Owen, Michael Palmer, Christopher Phillips, David Brown, Yvette Fobian, John Freskos, Steven Heasley, E. Jacobsen, Todd Maddux, Brent Mischke, John Molyneaux, Joseph Moon, D. Rogier, Michael Tollefson, John Walker